Pharmaceutical Corp. announced today that it has reached an agreement with its
Lender Committee with respect to the extension of the maturity date and restructuring
of the outstanding Senior Convertible Promissory Notes in the aggregate outstanding
principal amount of $10,476,250 (the "Senior Notes"). This agreement
must be approved by each and every holder of a Senior Note before it becomes effective.